Topoisomerase inhibitors for prevention of restenosis

A - Human Necessities – 61 – L

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61L 29/00 (2006.01) A61K 31/165 (2006.01) A61K 31/275 (2006.01) A61K 31/335 (2006.01) A61K 31/47 (2006.01) A61K 31/57 (2006.01) A61L 29/16 (2006.01) A61L 31/00 (2006.01) A61L 31/16 (2006.01)

Patent

CA 2335842

A method of inhibiting cellular proliferation associated with a hyperproliferative condition, such as restenosis, is described. The method includes administering a topoisomerase inhibitor. A stent for local administration of the topoisomerase inhibitor is also described.

Cette invention concerne un procédé permettant d'inhiber la prolifération cellulaire associée à des conditions d'hyper-prolifération, telles que la resténose. Ce procédé consiste à administrer un inhibiteur de topoisomérase. Cette invention concerne également un extenseur servant à l'administration locale de l'inhibiteur de topoisomérase.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Topoisomerase inhibitors for prevention of restenosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Topoisomerase inhibitors for prevention of restenosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topoisomerase inhibitors for prevention of restenosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1371694

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.